BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Acebes-Fernández V, Landeria-Viñuela A, Juanes-Velasco P, Hernández AP, Otazo-Perez A, Manzano-Román R, Gongora R, Fuentes M. Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. Nanomaterials (Basel) 2020;10:E1274. [PMID: 32610601 DOI: 10.3390/nano10071274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Ryabchikova E. Advances in Nanomaterials in Biomedicine. Nanomaterials (Basel) 2021;11:E118. [PMID: 33430171 DOI: 10.3390/nano11010118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Milewska S, Niemirowicz-Laskowska K, Siemiaszko G, Nowicki P, Wilczewska AZ, Car H. Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment. Int J Nanomedicine 2021;16:6593-644. [PMID: 34611400 DOI: 10.2147/IJN.S323831] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Meisami AH, Abbasi M, Mosleh-Shirazi S, Azari A, Amani AM, Vaez A, Golchin A. Self-propelled micro/nanobots: A new insight into precisely targeting cancerous cells through intelligent and deep cancer penetration. Eur J Pharmacol 2022;:175011. [PMID: 35568064 DOI: 10.1016/j.ejphar.2022.175011] [Reference Citation Analysis]
4 Giussani P, Prinetti A, Tringali C. The Role of Sphingolipids in Cancer Immunotherapy. Int J Mol Sci 2021;22:6492. [PMID: 34204326 DOI: 10.3390/ijms22126492] [Reference Citation Analysis]
5 Venkatas J, Singh M. Nanomedicine-mediated optimization of immunotherapeutic approaches in cervical cancer. Nanomedicine (Lond) 2021;16:1311-28. [PMID: 34027672 DOI: 10.2217/nnm-2021-0044] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu J, Chen J, Liu H, Zhang K, Zeng Q, Yang S, Jiang Z, Zhang X, Chen T, Li D, Shan H. Bi/Se-Based Nanotherapeutics Sensitize CT Image-Guided Stereotactic Body Radiotherapy through Reprogramming the Microenvironment of Hepatocellular Carcinoma. ACS Appl Mater Interfaces 2021;13:42473-85. [PMID: 34474563 DOI: 10.1021/acsami.1c11763] [Reference Citation Analysis]
7 Hernández ÁP, Juanes-Velasco P, Landeira-Viñuela A, Bareke H, Montalvillo E, Góngora R, Fuentes M. Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies. Cancers (Basel) 2021;13:2821. [PMID: 34198850 DOI: 10.3390/cancers13112821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Saravanakumar K, Anbazhagan S, Pujani Usliyanage J, Vishven Naveen K, Wijesinghe U, Xiaowen H, Vishnu Priya V, Thiripuranathar G, Wang MH. A comprehensive review on immuno-nanomedicine for breast cancer therapy: Technical challenges and troubleshooting measures. Int Immunopharmacol 2021;103:108433. [PMID: 34922248 DOI: 10.1016/j.intimp.2021.108433] [Reference Citation Analysis]
9 Juanes-velasco P, Galicia N, Pin E, Jara-acevedo R, Carabias-sánchez J, García-valiente R, Lecrevisse Q, Pedreira CE, Gongora R, Sanchez-santos JM, Lorenzo-gil H, Landeira-viñuela A, Bareke H, Orfao A, Nilsson P, Fuentes M. Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid. Cancers 2022;14:449. [DOI: 10.3390/cancers14020449] [Reference Citation Analysis]
10 Kusyak NV, Kusyak АP, Dudarko OA, Korniichuk NM, Petranovska AL, Gorbyk PP. Adsorption of doxorubicin on the surface of magnetically sensitive nanocomposite Fe 3 O 4 /Al 2 O 3 /С. Molecular Crystals and Liquid Crystals. [DOI: 10.1080/15421406.2022.2073525] [Reference Citation Analysis]
11 Juanes-Velasco P, Landeira-Viñuela A, Acebes-Fernandez V, Hernández ÁP, Garcia-Vaquero ML, Arias-Hidalgo C, Bareke H, Montalvillo E, Gongora R, Fuentes M. Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections. Front Cell Infect Microbiol 2021;11:642583. [PMID: 34123866 DOI: 10.3389/fcimb.2021.642583] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]